CompletedNot Applicable

Psychosocial Risk Factors in Stroke and Myocardial Infarction

France294 participantsStarted 2016-02-08

Plain-language summary

The aim of this study is to identify groups of subjects at risk of recurrence in secondary prevention based on Psychosocial Factors. The aim is also to propose novel levers to reduce health inequalities in this population so as to develop new prevention strategies for neuro- and cardio-vascular health This study is based on data from questionnaires (Quality of life at work, perceived stress, perceived disease severity) and on behavior indicators (factors related to lifestyle: alcohol, smoking, obesity, sedentarity). Biomarkers of endothelial function (ADMA) will also be assayed. It's an interventional study because of blood sample

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who have provided oral consent to participate * Patients over 18 years * Patients hospitalized for type 1 MI or ischemic stroke/TIA \< 24H after symptom onset * Age \< 65 years * With a professional activity (INSEE definition) at the time of the neuro or cardiovascular event * At least one of the following risk factors: current smoking, obesity (waist circumference \> 88 cm (W)/102 cm (M) or a waist/hip ratio 0.85(W)/0.9(M), sedentarity (physical activity \< 150 min / week), alcohol consumption (\> 3 standard glasses per day for men, \> 2 standard glasses/d for women) Exclusion Criteria: * Adult under guardianship * Patients without national health insurance cover * Pregnant or breast-feeding women * Clinical state making it impossible to use questionnaires or to measure risk factors * Stroke or TIA not related to atheroma or cardioembolism (dissection, hemopathy…) * type \> 1 MI

What they're measuring

number of psychosocial factors (PSF) on the level of risk for neuro-cardiovascular disease.

Timeframe: through the completion study an average of 6 month

Trial details

NCT IDNCT02824107

SponsorCentre Hospitalier Universitaire Dijon

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-08-26